本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

8.56
-0.5100-5.62%
成交量:6.98万
成交额:61.41万
市值:2.99亿
市盈率:-8.75
高:8.95
开:8.89
低:8.54
收:9.07
52周最高:16.76
52周最低:8.52
股本:3,488.27万
流通股本:1,845.34万
量比:0.53
换手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-0.9783
每股收益(LYR):-0.9800
净资产收益率:-33.21%
总资产收益率:-22.67%
市净率:1.69
市盈率(LYR):-8.73

数据加载中...

2023/09/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/03

SEC问询函

Form CORRESP - Correspondence
2023/08/03

SEC问询函

Form CORRESP - Correspondence
2023/07/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/07

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/08

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals